Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo- controlled extension study (vol 11, pg 425, 2023)

被引：0
|
作者：
Menzies-Gow, A.
Wechsler, M. E.
Brightling, C. E.
机构：
来源：
LANCET RESPIRATORY MEDICINE | 2023年 / 11卷 / 03期
关键词：
D O I：
10.1016/S2213-2600(23)00048-6
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：E25 / E25
页数：1
相关论文
共 50 条
  • [21] LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE OPEN-LABEL EXTENSION STUDY
    Pavord, Id
    Wechsler, Me
    Domingo, C.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Mao, X.
    Kapoor, U.
    Khokhar, Fa
    Mannent, Lp
    Ruddy, M.
    Laws, E.
    Amin, N.
    Hardin, M.
    THORAX, 2021, 76 : A81 - A82
  • [22] Long-term safety and efficacy of benralizumab in patients with severe, un-controlled asthma: 1-year results from the BORA phase 3 extension trial (vol 7, pg 46, 2019)
    Busse, W. W.
    Bleecker, E. R.
    FitzGerald, J. M.
    LANCET RESPIRATORY MEDICINE, 2019, 7 (01): : E1 - E1
  • [23] Long-Term Safety And Efficacy Of Reslizumab In Patients With Inadequately Controlled, Moderate-To-Severe Asthma And Elevated Blood Eosinophil Counts: An Open-Label Extension Study
    Murphy, K.
    Jacobs, J.
    Bjermer, L.
    Shalit, Y.
    Garin, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [24] Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
    Di Bona, Danilo
    Fiorino, Irene
    Taurino, Marialuisa
    Frisenda, Flavia
    Minenna, Elena
    Pasculli, Carlo
    Kourtis, Georgios
    Rucco, Anna Simona
    Nico, Andrea
    Albanesi, Marcello
    Giliberti, Lucia
    D'Elia, Luciana
    Caiaffa, Maria Filomena
    Macchia, Luigi
    RESPIRATORY MEDICINE, 2017, 130 : 55 - 60
  • [25] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Andrew Menzies-Gow
    Gene Colice
    Janet M. Griffiths
    Gun Almqvist
    Sandhia Ponnarambil
    Primal Kaur
    Gennaro Ruberto
    Karin Bowen
    Åsa Hellqvist
    May Mo
    Esther Garcia Gil
    Respiratory Research, 21
  • [26] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Menzies-Gow, Andrew
    Colice, Gene
    Griffiths, Janet M.
    Almqvist, Gun
    Ponnarambil, Sandhia
    Kaur, Primal
    Ruberto, Gennaro
    Bowen, Karin
    Hellqvist, Asa
    Mo, May
    Garcia Gil, Esther
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [27] Efficacy, Safety, and Tolerability of Lebrikizumab in Adolescent Patients with Uncontrolled Asthma (ACOUSTICS): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Study
    Szefler, S.
    Roberts, G.
    Rubin, A. S.
    Zielen, S.
    Kuna, P.
    Alpan, O.
    Anzures-Cabrera, J.
    Chen, Q.
    Holweg, C. T. J.
    Kaminski, J.
    Putnam, W.
    Matthews, J. G.
    Kamath, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [28] Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION) : an open-label extension study
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Katelaris, Constance H.
    Fiocchi, Alessandro G.
    Gagnon, Remi
    de Mir, Ines
    Guilbert, Theresa W.
    Jackson, Daniel J.
    Staudinger, Heribert W.
    Laws, Elizabeth
    Mannent, Leda P.
    Akinlade, Bolanle
    Maloney, Jennifer
    Tawo, Kelsey
    Khokhar, Faisal A.
    Li, Ning
    Hardin, Megan
    Abdulai, Raolat M.
    Lederer, David J.
    Robinson, Lacey B.
    LANCET RESPIRATORY MEDICINE, 2024, 12 (01): : 45 - 54
  • [29] Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial (vol 9, pg 1299, 2021)
    Diver, S.
    Khalfaoui, L.
    Emson, C.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (11): : E106 - E106
  • [30] Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial
    Goldstone, Stephen E.
    Giuliano, Anna R.
    Palefsky, Joel M.
    Lazcano-Ponce, Eduardo
    Penny, Mary E.
    Cabello, Robinson E.
    Moreira, Edson D.
    Baraldi, Ezio
    Jessen, Heiko
    Ferenczy, Alex
    Kurman, Robert
    Ronnett, Brigitte M.
    Stoler, Mark H.
    Bautista, Oliver
    Das, Rituparna
    Group, Thomas
    Luxembourg, Alain
    Zhou, Hao Jin
    Saah, Alfred
    LANCET INFECTIOUS DISEASES, 2022, 22 (03): : 413 - 425
12345